{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:01:28Z","timestamp":1784613688059,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Research Project of Jining Medical College Affiliated Hospital","award":["LCYJ-18"],"award-info":[{"award-number":["LCYJ-18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05600-1","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:15:58Z","timestamp":1784304958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applications of circulating tumor cells in esophageal cancer detection and treatment"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0600-3134","authenticated-orcid":false,"given":"Fangyuan","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6515-2529","authenticated-orcid":false,"given":"Ronghang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"4","key":"5600_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10585-023-10248-0","volume":"41","author":"C Rodriguez-Tirado","year":"2024","unstructured":"Rodriguez-Tirado C, Sosa MS. How much do we know about the metastatic process? Clin Exp Metastasis. 2024;41(4):275\u201399.","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"5600_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"5600_CR3","unstructured":"Yao Y, Sun, Zheng R. Analysis and Interpretation of the 2022 Global Cancer Statistics Report: a Comparison Between China and the World. Chin J Gen Surgery Basic Clin. 2024:1\u201312."},{"issue":"6","key":"5600_CR4","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5600_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(4):393\u2013422.","journal-title":"J Natl Compr Canc Netw"},{"issue":"17","key":"5600_CR6","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.ejca.2014.08.020","volume":"50","author":"AH H\u00f6lscher","year":"2014","unstructured":"H\u00f6lscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer\u2014a propensity score matched analysis. Eur J Cancer. 2014;50(17):2950\u20137.","journal-title":"Eur J Cancer"},{"issue":"24","key":"5600_CR7","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1200\/JCO.2007.14.3065","volume":"26","author":"JV Frangioni","year":"2008","unstructured":"Frangioni JV. New technologies for human cancer imaging. J Clin Oncol. 2008;26(24):4012\u201321.","journal-title":"J Clin Oncol"},{"key":"5600_CR8","doi-asserted-by":"publisher","first-page":"827297","DOI":"10.3389\/fmed.2022.827297","volume":"9","author":"R Iacob","year":"2022","unstructured":"Iacob R, Mandea M, Iacob S, Pietrosanu C, Paul D, Hainarosie R, Gheorghe C. Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck. Front Med (Lausanne). 2022;9:827297.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"5600_CR9","first-page":"619","volume":"81","author":"I Salgado","year":"1959","unstructured":"Salgado I, Hopkirk JF, Long RC, Ritchie AC, Ritchie S, Webster DR. Tumour cells in the blood. Can Med Assoc J. 1959;81(8):619\u201322.","journal-title":"Can Med Assoc J"},{"key":"5600_CR10","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.eclinm.2021.101161","volume":"43","author":"Z Yang","year":"2022","unstructured":"Yang Z, Bai H, Hu L, Kong D, Li G, Zhao C, Feng L, Cheng S, Shou J, Zhang W, et al. Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: a prospective pilot study. EClinicalMedicine. 2022;43:101161.","journal-title":"EClinicalMedicine"},{"issue":"25","key":"5600_CR11","doi-asserted-by":"publisher","first-page":"30174","DOI":"10.1021\/acsami.1c06337","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang J, Li Y, Wang R, Han C, Xu S, You T, Li Y, Xia J, Xu X, Wang D, et al. A Fully Automated and Integrated Microfluidic System for Efficient CTC Detection and its Application in Hepatocellular Carcinoma Screening and Prognosis. ACS Appl Mater Interfaces. 2021;13(25):30174\u201386.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"5600_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s13402-023-00774-0","volume":"46","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xie P, Zhang K, Zhang W. Circulating tumour cell isolation, analysis and clinical application. Cell Oncol (Dordr). 2023;46(3):533\u201344.","journal-title":"Cell Oncol (Dordr)"},{"issue":"7634","key":"5600_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini H, Obradovi\u0107 MMS, Hoffmann M, Harper KL, Sosa MS, Werner-Klein M, Nanduri LK, Werno C, Ehrl C, Maneck M, et al. Early dissemination seeds metastasis in breast cancer. Nature. 2016;540(7634):552\u20138.","journal-title":"Nature"},{"issue":"11","key":"5600_CR14","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1172\/JCI70354","volume":"123","author":"MC Haffner","year":"2013","unstructured":"Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA, Adejola N, G\u00fcrel M, Hicks J, Meeker AK, et al. Tracking the clonal origin of lethal prostate cancer. J Clin Invest. 2013;123(11):4918\u201322.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"5600_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148(1\u20132):349\u201361.","journal-title":"Cell"},{"issue":"3","key":"5600_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ccr.2005.08.003","volume":"8","author":"JA Schardt","year":"2005","unstructured":"Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, Fuhrmann C, Polzer B, Petronio M, Eils R, Klein CA. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell. 2005;8(3):227\u201339.","journal-title":"Cancer Cell"},{"issue":"4","key":"5600_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9(4):302\u201312.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5600_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 2017;168(4):670\u201391.","journal-title":"Cell"},{"issue":"8","key":"5600_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1158\/1541-7786.MCR-10-0490","volume":"9","author":"AJ Armstrong","year":"2011","unstructured":"Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res. 2011;9(8):997\u20131007.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"5600_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.18632\/aging.203888","volume":"14","author":"H Tao","year":"2022","unstructured":"Tao H, Zhang Y, Yuan T, Li J, Liu J, Xiong Y, Zhu J, Huang Z, Wang P, Liang H, et al. Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma. Aging. 2022;14(3):1473\u201391.","journal-title":"Aging"},{"issue":"11","key":"5600_CR21","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3390\/jcm10112403","volume":"10","author":"L van Bornes","year":"2021","unstructured":"Bornes L, Belthier G, van Rheenen J. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E\/M States. J Clin Med. 2021;10(11):2403.","journal-title":"J Clin Med"},{"key":"5600_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","volume":"19","author":"R Fontana","year":"2024","unstructured":"Fontana R, Mestre-Farrera A, Yang J. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression. Annu Rev Pathol. 2024;19:133\u201356.","journal-title":"Annu Rev Pathol"},{"issue":"20","key":"5600_CR23","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","volume":"188","author":"CX Zhang","year":"2025","unstructured":"Zhang CX, Huang RY, Sheng G, Thiery JP. Epithelial-mesenchymal transition. Cell. 2025;188(20):5436\u201386.","journal-title":"Cell"},{"issue":"3","key":"5600_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","volume":"14","author":"M Mohme","year":"2017","unstructured":"Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat Rev Clin Oncol. 2017;14(3):155\u201367.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"5600_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41392-024-01789-1","volume":"9","author":"C Yang","year":"2024","unstructured":"Yang C, Wang X, To KKW, Cui C, Luo M, Wu S, Huang L, Fu K, Pan C, Liu Z, et al. Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis. Signal Transduct Target Ther. 2024;9(1):84.","journal-title":"Signal Transduct Target Ther"},{"issue":"7586","key":"5600_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massagu\u00e9","year":"2016","unstructured":"Massagu\u00e9 J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529(7586):298\u2013306.","journal-title":"Nature"},{"issue":"5","key":"5600_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110\u201322.","journal-title":"Cell"},{"issue":"1","key":"5600_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43856-024-00702-9","volume":"5","author":"A Meunier","year":"2025","unstructured":"Meunier A, Hern\u00e1ndez-Castro JA, Chahley N, Communal L, Kheireddine S, Koushki N, Davoudvandi N, Al Habyan S, P\u00e9ant B, Lazaris A, et al. Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer. Commun Med (Lond). 2025;5(1):33.","journal-title":"Commun Med (Lond)"},{"issue":"7745","key":"5600_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, Scheidmann MC, Donato C, Scherrer R, Singer J, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566(7745):553\u20137.","journal-title":"Nature"},{"key":"5600_CR30","doi-asserted-by":"publisher","first-page":"216757","DOI":"10.1016\/j.canlet.2024.216757","volume":"588","author":"Q Wu","year":"2024","unstructured":"Wu Q, Gu Z, Shang B, Wan D, Zhang Q, Zhang X, Xie P, Cheng S, Zhang W, Zhang K. Circulating tumor cell clustering modulates RNA splicing and polyadenylation to facilitate metastasis. Cancer Lett. 2024;588:216757.","journal-title":"Cancer Lett"},{"key":"5600_CR31","doi-asserted-by":"publisher","first-page":"641187","DOI":"10.3389\/fonc.2021.641187","volume":"11","author":"TA Allen","year":"2021","unstructured":"Allen TA, Cullen MM, Hawkey N, Mochizuki H, Nguyen L, Schechter E, Borst L, Yoder JA, Freedman JA, Patierno SR, et al. A Zebrafish Model of Metastatic Colonization Pinpoints Cellular Mechanisms of Circulating Tumor Cell Extravasation. Front Oncol. 2021;11:641187.","journal-title":"Front Oncol"},{"issue":"5","key":"5600_CR32","doi-asserted-by":"publisher","first-page":"109547","DOI":"10.1016\/j.isci.2024.109547","volume":"27","author":"W Zhou","year":"2024","unstructured":"Zhou W, Zhu C, Shen P, Wang JF, Zhu G, Jia Y, Wu Y, Wang S, Sun J, Yang F, et al. Hypoxia stimulates CTC-platelet cluster formation to promote breast cancer metastasis. iScience. 2024;27(5):109547.","journal-title":"iScience"},{"key":"5600_CR33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41591-024-03486-6","volume":"31","author":"C Kurzeder","year":"2025","unstructured":"Kurzeder C, Nguyen-Str\u00e4uli BD, Krol I, Ring A, Castro-Giner F, N\u00fcesch M, Asawa S, Zhang YW, Budinjas S, Gvozdenovic A, et al. Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial. Nat Med. 2025;31:1120\u20134.","journal-title":"Nat Med"},{"issue":"7","key":"5600_CR34","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s44321-024-00082-6","volume":"16","author":"M Sementsov","year":"2024","unstructured":"Sementsov M, Ott L, K\u00f6tt J, Sartori A, Lusque A, Degenhardt S, Segier B, Heidrich I, Volkmer B, Greinert R, et al. Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma. EMBO Mol Med. 2024;16(7):1560\u201378.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"5600_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13046-024-03149-x","volume":"43","author":"M Ciccioli","year":"2024","unstructured":"Ciccioli M, Kim K, Khazan N, Khoury JD, Cooke MJ, Miller MC, O\u2019Shannessy DJ, Pailhes-Jimenez AS, Moore RG. Identification of circulating tumor cells captured by the FDA-cleared Parsortix(\u00ae) PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations. J Exp Clin Cancer Res. 2024;43(1):240.","journal-title":"J Exp Clin Cancer Res"},{"key":"5600_CR36","doi-asserted-by":"publisher","first-page":"114059","DOI":"10.1016\/j.colsurfb.2024.114059","volume":"241","author":"V Roschenko","year":"2024","unstructured":"Roschenko V, Schorr D, Wojcik M, Amin MU, Bakowsky U, Preis E. An innovative approach to detect circulating tumor cells. Colloids Surf B Biointerfaces. 2024;241:114059.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"18","key":"5600_CR37","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1021\/acs.analchem.3c02769","volume":"96","author":"J Wang","year":"2024","unstructured":"Wang J, Liu X, Li J, Chen W. Digital Circulating Tumor Cells Quantification. Anal Chem. 2024;96(18):6881\u20138.","journal-title":"Anal Chem"},{"issue":"18","key":"5600_CR38","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1021\/acs.analchem.3c05371","volume":"96","author":"C Magnusson","year":"2024","unstructured":"Magnusson C, Augustsson P, Undvall Anand E, Lenshof A, Josefsson A, Wel\u00e9n K, Bjartell A, Ceder Y, Lilja H, Laurell T. Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients. Anal Chem. 2024;96(18):6914\u201321.","journal-title":"Anal Chem"},{"issue":"45","key":"5600_CR39","doi-asserted-by":"publisher","first-page":"31135","DOI":"10.1021\/acsnano.4c08893","volume":"18","author":"L Lu","year":"2024","unstructured":"Lu L, Wang Y, Ding Y, Wang Y, Zhu Z, Lu J, Yang L, Zhang P, Yang C. Profiling Phenotypic Heterogeneity of Circulating Tumor Cells through Spatially Resolved Immunocapture on Nanoporous Micropillar Arrays. ACS Nano. 2024;18(45):31135\u201347.","journal-title":"ACS Nano"},{"issue":"21","key":"5600_CR40","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/cancers14215238","volume":"14","author":"EN Cohen","year":"2022","unstructured":"Cohen EN, Jayachandran G, Moore RG, Cristofanilli M, Lang JE, Khoury JD, Press MF, Kim KK, Khazan N, Zhang Q, et al. A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(\u00ae) PC1 System. Cancers (Basel). 2022;14(21):5238.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"5600_CR41","doi-asserted-by":"publisher","first-page":"104696","DOI":"10.1016\/j.isci.2022.104696","volume":"25","author":"JF Edd","year":"2022","unstructured":"Edd JF, Mishra A, Smith KC, Kapur R, Maheswaran S, Haber DA, Toner M. Isolation of circulating tumor cells. iScience. 2022;25(8):104696.","journal-title":"iScience"},{"issue":"1","key":"5600_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41467-024-55140-x","volume":"16","author":"A Mishra","year":"2025","unstructured":"Mishra A, Huang SB, Dubash T, Burr R, Edd JF, Wittner BS, Cunneely QE, Putaturo VR, Deshpande A, Antmen E, et al. Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Nat Commun. 2025;16(1):32.","journal-title":"Nat Commun"},{"issue":"9","key":"5600_CR43","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/ijc.34301","volume":"152","author":"H Zhu","year":"2023","unstructured":"Zhu H, Ma X, Ye T, Wang H, Wang Z, Liu Q, Zhao K. Esophageal cancer in China: Practice and research in the new era. Int J Cancer. 2023;152(9):1741\u201351.","journal-title":"Int J Cancer"},{"issue":"10","key":"5600_CR44","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1158\/1078-0432.CCR-06-2072","volume":"13","author":"Z Liu","year":"2007","unstructured":"Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res. 2007;13(10):2992\u20137.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"5600_CR45","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1245\/s10434-010-1075-3","volume":"17","author":"K Tanaka","year":"2010","unstructured":"Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Ohue M, et al. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer. Ann Surg Oncol. 2010;17(10):2779\u201386.","journal-title":"Ann Surg Oncol"},{"key":"5600_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2407-11-126","volume":"11","author":"I Andolfo","year":"2011","unstructured":"Andolfo I, Petrosino G, Vecchione L, De Antonellis P, Capasso M, Montanaro D, Gemei M, Troncone G, Iolascon A, Orditura M, et al. Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma. BMC Cancer. 2011;11:126.","journal-title":"BMC Cancer"},{"issue":"38","key":"5600_CR47","doi-asserted-by":"publisher","first-page":"e1565","DOI":"10.1097\/MD.0000000000001565","volume":"94","author":"H Li","year":"2015","unstructured":"Li H, Song P, Zou B, Liu M, Cui K, Zhou P, Li S, Zhang B. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches. Med (Baltim). 2015;94(38):e1565.","journal-title":"Med (Baltim)"},{"key":"5600_CR48","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/OTT.S129004","volume":"10","author":"Y Qiao","year":"2017","unstructured":"Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D. Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2017;10:1363\u201373.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"5600_CR49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/jgh.14543","volume":"34","author":"MK Choi","year":"2019","unstructured":"Choi MK, Kim GH, Park IH, Lee SJ, Lee MW, Park BE, Cho DY. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2019;34(3):552\u201360.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"5600_CR50","first-page":"1551","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li J, Wang L, Meng P, Zhao J, Han P, Xia J, Xu J, Wang L, Shen F, et al. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM\u2013independent enrichment and immunostaining\u2013fluorescence in situ hybridization. Mol Med Rep. 2019;20(2):1551\u201360.","journal-title":"Mol Med Rep"},{"key":"5600_CR51","doi-asserted-by":"publisher","first-page":"828368","DOI":"10.3389\/fonc.2022.828368","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Wang Z, Fu R, Wang S, Zhang T, Tian X, Yang D. Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer. Front Oncol. 2022;12:828368.","journal-title":"Front Oncol"},{"issue":"8","key":"5600_CR52","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/bjs.4593","volume":"91","author":"J Kaganoi","year":"2004","unstructured":"Kaganoi J, Shimada Y, Kano M, Okumura T, Watanabe G, Imamura M. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg. 2004;91(8):1055\u201360.","journal-title":"Br J Surg"},{"issue":"11","key":"5600_CR53","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1245\/s10434-008-0122-9","volume":"15","author":"K Hiraiwa","year":"2008","unstructured":"Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, Kumagai K, Irino T, Yoshikawa T, Matsuda S, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol. 2008;15(11):3092\u2013100.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5600_CR54","first-page":"94","volume":"13","author":"F Sclafani","year":"2014","unstructured":"Sclafani F, Smyth E, Cunningham D, Chau I, Turner A, Watkins D. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers. Clin Colorectal Cancer. 2014;13(2):94\u20139.","journal-title":"Clin Colorectal Cancer"},{"issue":"11","key":"5600_CR55","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1245\/s10434-015-4392-8","volume":"22","author":"D Matsushita","year":"2015","unstructured":"Matsushita D, Uenosono Y, Arigami T, Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima H, Kijima Y, et al. Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2015;22(11):3674\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"5600_CR56","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/SLA.0000000000001130","volume":"261","author":"M Reeh","year":"2015","unstructured":"Reeh M, Effenberger KE, Koenig AM, Riethdorf S, Eichst\u00e4dt D, Vettorazzi E, Uzunoglu FG, Vashist YK, Izbicki JR, Pantel K, et al. Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer. Ann Surg. 2015;261(6):1124\u201330.","journal-title":"Ann Surg"},{"key":"5600_CR57","doi-asserted-by":"publisher","first-page":"31423","DOI":"10.1038\/srep31423","volume":"6","author":"PJ Su","year":"2016","unstructured":"Su PJ, Wu MH, Wang HM, Lee CL, Huang WK, Wu CE, Chang HK, Chao YK, Tseng CK, Chiu TK, et al. Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy. Sci Rep. 2016;6:31423.","journal-title":"Sci Rep"},{"issue":"1","key":"5600_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3892\/ol.2023.13906","volume":"26","author":"T Akashi","year":"2023","unstructured":"Akashi T, Okumura T, Terabayashi K, Yoshino Y, Tanaka H, Yamazaki T, Numata Y, Fukuda T, Manabe T, Baba H, et al. The use of an artificial intelligence algorithm for circulating tumor cell detection in patients with esophageal cancer. Oncol Lett. 2023;26(1):320.","journal-title":"Oncol Lett"},{"issue":"1","key":"5600_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40364-024-00718-2","volume":"13","author":"W Jin","year":"2025","unstructured":"Jin W, Huang K, Ding Z, Zhang M, Li C, Yuan Z, Ma K, Ye X. Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021. Biomark Res. 2025;13(1):3.","journal-title":"Biomark Res"},{"key":"5600_CR60","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2147\/CMAR.S150350","volume":"9","author":"SG Wu","year":"2017","unstructured":"Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781\u20138.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"5600_CR61","doi-asserted-by":"publisher","first-page":"e13921","DOI":"10.1097\/MD.0000000000013921","volume":"98","author":"L Han","year":"2019","unstructured":"Han L, Li YJ, Zhang WD, Song PP, Li H, Li S. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Med (Baltim). 2019;98(6):e13921.","journal-title":"Med (Baltim)"},{"issue":"3","key":"5600_CR62","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/cancers15030832","volume":"15","author":"JMY Ko","year":"2023","unstructured":"Ko JMY, Lam KO, Kwong DLW, Wong IY, Chan FS, Wong CL, Chan KK, Law TT, Chiu KWH, Lam CCS, et al. Circulating Tumor Cell Enumeration for Serial Monitoring of Treatment Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2023;15(3):832.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"5600_CR63","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.21037\/apm-20-590","volume":"9","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Deng H, Chen G, Tang Z, Mao J, Mi Y, Cui S, Zhang Y, Wang N, Wang L. Clinicopathological and prognostic value of circulating tumor cells in esophageal carcinoma: a meta-analysis. Ann Palliat Med. 2020;9(6):4271\u201382.","journal-title":"Ann Palliat Med"},{"key":"5600_CR64","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2147\/OTT.S100005","volume":"9","author":"GL Qiao","year":"2016","unstructured":"Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ. Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis. Onco Targets Ther. 2016;9:1889\u201397.","journal-title":"Onco Targets Ther"},{"issue":"51","key":"5600_CR65","doi-asserted-by":"publisher","first-page":"e36603","DOI":"10.1097\/MD.0000000000036603","volume":"102","author":"J Wu","year":"2023","unstructured":"Wu J, Wang WX, Zhou Y, Yang DS, Wu ZN, Li X, Tang JM. Expression of PTP4A1 in circulating tumor cells and its efficacy evaluation in patients with early- and intermediate-stage esophageal cancer. Med (Baltim). 2023;102(51):e36603.","journal-title":"Med (Baltim)"},{"key":"5600_CR66","doi-asserted-by":"publisher","first-page":"103067","DOI":"10.1016\/j.eclinm.2024.103067","volume":"80","author":"H van Laarhoven","year":"2025","unstructured":"van Laarhoven H, Verhoeven R, van Berge Henegouwen M, Mohammad NH, van Hillegersberg R, Slingerland M, Muijs CT, Wijnhoven B, Mostert B, Beerepoot L, et al. Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands. EClinicalMedicine. 2025;80:103067.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"5600_CR67","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s11912-024-01606-6","volume":"26","author":"ET Santos","year":"2024","unstructured":"Santos ET, Baig D, Sanford NN. Current Standards and Controversies in Multidisciplinary Management of Locoregional Gastroesophageal Junction Tumors. Curr Oncol Rep. 2024;26(12):1606\u201311.","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"5600_CR68","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhang Y, Ma N, Yang Y, Ma Y, Wang F, Wang Y, Wei J, Chen H, Tartarone A, et al. Progenitor-like exhausted SPRY1(+)CD8(+) T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell. 2023;41(11):1852\u2013e18701859.","journal-title":"Cancer Cell"},{"issue":"9","key":"5600_CR69","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","volume":"30","author":"J Qin","year":"2024","unstructured":"Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, Liu S, Chen Y, Jiang H, Zhang C, et al. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO\/NCCES01 trial. Nat Med. 2024;30(9):2549\u201357.","journal-title":"Nat Med"},{"issue":"22","key":"5600_CR70","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"5600_CR71","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-024-02006-x","volume":"23","author":"P Yue","year":"2024","unstructured":"Yue P, Bie F, Zhu J, Gao LR, Zhou Z, Bai G, Wang X, Zhao Z, Xiao ZF, Li Y, et al. Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma. Mol Cancer. 2024;23(1):96.","journal-title":"Mol Cancer"},{"issue":"23","key":"5600_CR72","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.3390\/cancers16233960","volume":"16","author":"S Tatalovic","year":"2024","unstructured":"Tatalovic S, Doleschal B, Kupferthaler A, Grundner S, Burghofer J, Webersinke G, Schwendinger S, Jukic E, Zschocke J, Danhel L, et al. Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment. Cancers (Basel). 2024;16(23):3960.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5600_CR73","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41467-024-46307-7","volume":"15","author":"B Chen","year":"2024","unstructured":"Chen B, Liu S, Zhu Y, Wang R, Cheng X, Chen B, Dragomir MP, Zhang Y, Hu Y, Liu M, et al. Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab. Nat Commun. 2024;15(1):1919.","journal-title":"Nat Commun"},{"issue":"4","key":"5600_CR74","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41591-024-02877-z","volume":"30","author":"RJ Kelly","year":"2024","unstructured":"Kelly RJ, Landon BV, Zaidi AH, Singh D, Canzoniero JV, Balan A, Hales RK, Voong KR, Battafarano RJ, Jobe BA, et al. Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal\/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nat Med. 2024;30(4):1023\u201334.","journal-title":"Nat Med"},{"issue":"12","key":"5600_CR75","doi-asserted-by":"publisher","first-page":"8157","DOI":"10.1245\/s10434-024-16041-x","volume":"31","author":"X Sun","year":"2024","unstructured":"Sun X, Lyu J, Yang M, Lin Y, Wu K, Liu K, Li A, Shuai X, Cai K, Wang Z, et al. Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial. Ann Surg Oncol. 2024;31(12):8157\u201369.","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"5600_CR76","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.3390\/ijms26199583","volume":"26","author":"I Sumiyoshi","year":"2025","unstructured":"Sumiyoshi I, Togo S, Okabe T, Abe K, Watanabe J, Ochi Y, Hoshi K, Saiwaki S, Nojiri S, Fujimoto Y, et al. Dynamics of Telomerase-Based PD-L1 Circulating Tumor Cells as a Longitudinal Biomarker for Treatment Response Prediction in Patients with Non-Small Cell Lung Cancer. Int J Mol Sci. 2025;26(19):9583.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5600_CR77","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/CM9.0000000000003738","volume":"139","author":"S Chen","year":"2026","unstructured":"Chen S, Zhang S, Shi Y, Liu X. Microenvironment crosstalk and immune evasion of circulating tumor cells: from mechanism to clinical significance. Chin Med J (Engl). 2026;139(4):515\u201335.","journal-title":"Chin Med J (Engl)"},{"key":"5600_CR78","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.2147\/CMAR.S337489","volume":"13","author":"Y Shi","year":"2021","unstructured":"Shi Y, Ge X, Ju M, Zhang Y, Di X, Liang L. Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma-Mini Review. Cancer Manag Res. 2021;13:8355\u201365.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"5600_CR79","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12885-020-07059-x","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Wu G, Yang W, Wang X, Duan L, Niu L, Zhang Y, Liu J, Hong L, Fan D. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):581.","journal-title":"BMC Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05600-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:02:45Z","timestamp":1784610165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05600-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5600"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05600-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a review article and does not involve human participants, animal experiments, or original clinical data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and agreed to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1056"}}